This HTML document is not a form. Its purpose is to display the information as found on the form for viewing purposes only. If you wish to use the form, you must use the alternate format below.
Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
1. Type
2a. Date of last inspection or SQAR completion
2b. Type of inspection:
3. Building Name
4. Building Number (if more than 1 sQAR submitted) of (one SQAR per building)
5. Dwelling House
Yes
No
6. Address, Number/Street/Suite/Land Location
7. City-Town
8. Province/State
9. Postal Code/Zip Code
10. Country
CANADA
11.
| Add | Non-Sterile HM Dosage Form(s) | Sterile HM Dosage Form(s) | |
|---|---|---|---|
| Manufacturing | |||
| Packaging | |||
| Labelling |
12a. Print the Name of Quality Assurance Person (in Section 28 (f)) who completed the QAR for the building listed in box #3 of this form:
12b.
13a. Print the Name of Quality Assurance Person who is responsible for ensuring Section 51 of the Natural Health Products Regulations (approving the materials, methods and procedures; approving product release for sale and resale; and investigating and recording complaints) is met:
13b.
I attest that the building(s), practice(s) and procedure(s) used for conducting activities in our facility comply with the good manufacturing practices set out in Part 3 of the Natural Health Products Regulations
Name of Quality Assurance Person (Please print)
Signature of QA Person Date
yyyy-mm-dd
1. Building is designed to accommodate storage and processing of homeopathic medicine:
If yes, describe for (a) and (b) how the premise's design complies with NHP GMPs.
If no, provide a rationale.
Relevant standard operating procedures are established. Yes No
List all standard operating procedures (SOPs) (titles and numbers) for this section.
Identify and describe any noted GMP deviation(s) and the rationale for the deviation, where applicable. Detail the corrective action(s) taken and/or to be taken.
List of attachments:
2. Authorized personnel working in areas designed for attenuation and trituration have the appropriate training and attire. Yes No
If yes, describe how individual(s) meet the requirements to perform their duties relating to the activities, types of natural health products and dosage forms.
If no, provide a rationale.
Relevant standard operating procedures are established. Yes No
List all standard operating procedures (SOPs) (titles and numbers) for this section.
Identify and describe any noted GMP deviation(s) and the rationale for the deviation, where applicable. Detail the corrective action(s) taken and/or to be taken.
List of attachments:
3. A sanitation program has been established to include:
If yes, for (a), (b) and (c) describe.
If no, provide a rationale.
Relevant standard operating procedures are established. Yes No
List all standard operating procedures (SOPs) (titles and numbers) for this section.
Identify and describe any noted GMP deviation(s) and the rationale for the deviation, where applicable. Detail the corrective action(s) taken and/or to be taken.
List of attachments:
4. Procedures are in place for handling raw material(s) that are potentially toxic. Yes No
If yes, describe.
If no, provide a rationale.
Relevant standard operating procedures are established. Yes No
List all standard operating procedures (SOPs) (titles and numbers) for this section.
Identify and describe any noted GMP deviation(s) and the rationale for the deviation, where applicable. Detail the corrective action(s) taken and/or to be taken.
List of attachments:
5. Critical production processes are controlled (such as labelling equipment, containers and raw materials used during in-process stages). Yes No
If yes, describe.
If no, provide a rationale.
Relevant standard operating procedures are established. Yes No
List all standard operating procedures (SOPs) (titles and numbers) for this section.
Identify and describe any noted GMP deviation(s) and the rationale for the deviation, where applicable. Detail the corrective action(s) taken and/or to be taken.
List of attachments:
6. Control systems for critical production processes are in place (e.g. measures to ensure adequacy of heat processing of the first attenuation in the preparation of nosodes). Yes No
If yes, describe.
If no, provide a rationale.
Relevant standard operating procedures are established. Yes No
List all standard operating procedures (SOPs) (titles and numbers) for this section.
Identify and describe any noted GMP deviation(s) and the rationale for the deviation, where applicable. Detail the corrective action(s) taken and/or to be taken.
List of attachments:
7. The master formula includes special precautions that may be relevant to the particular classification of preparation (e.g. nosodes). Yes No
If yes, describe.
If no, provide a rationale.
Relevant standard operating procedures are established. Yes No
List all standard operating procedures (SOPs) (titles and numbers) for this section.
Identify and describe any noted GMP deviation(s) and the rationale for the deviation, where applicable. Detail the corrective action(s) taken and/or to be taken.
List of attachments:
8. All homeopathic products are prepared in accordance with specifications that include the methods outlined in one of the homeopathic pharmacopoeias *.
* Such as the Homeopathic Pharmacopeia of the United States (HPUS) or German Homeopathic Pharmacopoeia (GHP).
Yes No
If yes, describe.
If no, provide a rationale.
Relevant standard operating procedures are established. Yes No
List all standard operating procedures (SOPs) (titles and numbers) for this section.
Identify and describe any noted GMP deviation(s) and the rationale for the deviation, where applicable. Detail the corrective action(s) taken and/or to be taken.
List of attachments:
9. Procedures are in place to ensure that the expiry date of an attenuation does not exceed that of the raw material(s) from which it is prepared. Yes No
If yes, describe.
If no, provide a rationale.
Relevant standard operating procedures are established. Yes No
List all standard operating procedures (SOPs) (titles and numbers) for this section.
Identify and describe any noted GMP deviation(s) and the rationale for the deviation, where applicable. Detail the corrective action(s) taken and/or to be taken.
List of attachments:
| Questions of the QAR | Record Type | Check Box | Relevant sections of the NHPR | *Quality Technical Agreement | Example of Acceptable Record Types |
|---|---|---|---|---|---|
| 1 | Building Design | 45 | Floor plan, air filtration, water quality and system maintenance records… | ||
| 2 | Personnel Training | 47 | Certificates of data logs (with trainee signature) of on-going GMP training (specific to homeopathic manufacturing, internal or external) | ||
| 3 | Premise, Equipment and Utensils Cleaning | 48 | Data logs of site/facility Cleaning (production and non production area) and equipment cleaning (specific to homeopathic manufacturing, including schedules and frequencies) | ||
| 4 | Raw Material Handling and Control | 49, 51(2) | SOPs, certificates of analysis, material release forms, batch records, master production documents, out of specifications investigation reports… | ||
| 5-7 | Process Control | 49 | Batch records, master production documents, out of specifications investigation reports | ||
| 8 | Specifications | 44, 51(4) | Specification sheet including the reference to the homeopathic pharmacopoeia, certificate of Analysis, batch records of finished products and raw materials, if applicable. | ||
| 9 | Stability | 52 | Data logs from accelerated or real-time stability studies (must show product meets its label claim at time of expiry), raw material stability data. |
*Please provide copies of signed and dated quality technical agreements along with the relevant record samples as evidence.